Robert J. Perez, Director at Cidara Therapeutics, Inc. (CDTX), bought 5,000 shares at $16.00 ($80K) on 2015-04-20, disclosed to the SEC on 2015-04-21.
Open-market purchase of $80k CDTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CBST | SELL | 2014-05-14 | $166K | — | Filing → |
| CBST | SELL | 2014-02-28 | $2.4M | — | Filing → |
| CBST | SELL | 2014-02-19 | $263K | — | Filing → |